| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.39 | 0.03 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.3 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.28 | 0.04 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.27 | 0.05 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |